We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

30 hedge funds and large institutions have $8.5M invested in Tempest Therapeutics in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

306% more call options, than puts

Call options by funds: $130K | Put options by funds: $32K

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

19% less funds holding

Funds holding: 37 → 30 (-7)

48% less capital invested

Capital invested by funds: $16.4M → $8.5M (-$7.94M)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

Holders
30
Holders Change
-7
Holders Change %
-18.92%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
7
Closed
12
Calls
$130K
Puts
$32K
Net Calls
+$98K
Net Calls Change
+$53K

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$2.51M
2
MIM
Monashee Investment Management
Massachusetts
+$1.04M
3
Renaissance Technologies
Renaissance Technologies
New York
+$762K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$395K
5
BFM
Boothbay Fund Management
New York
+$297K

Top Sellers

Rank Fund Capital Flow
1
CC
Commodore Capital
New York
-$1.98M
2
GTC
Ghost Tree Capital
New York
-$1.98M
3
Barclays
Barclays
United Kingdom
-$874K
4
Citadel Advisors
Citadel Advisors
Florida
-$863K
5
AFM
Anson Funds Management
Texas
-$715K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1K – – –
Bank of America
27
Bank of America
North Carolina
$1K +$2.42K +6 New
FDCDDQ
28
Federation des caisses Desjardins du Quebec
Quebec, Canada
$12 – – –
RE
29
RBC Europe
United Kingdom
$7 – – –
CC
30
Commodore Capital
New York
– -$1.98M -4,744 Closed
GTC
31
Ghost Tree Capital
New York
– -$1.98M -4,744 Closed
AFM
32
Anson Funds Management
Texas
– -$715K -1,713 Closed
GPP
33
Great Point Partners
Connecticut
– -$578K -1,385 Closed
JP Morgan Chase
34
JP Morgan Chase
New York
– -$156K -386 Closed
VF
35
Virtu Financial
New York
– -$66K -158 Closed
Group One Trading
36
Group One Trading
Illinois
– -$46.5K -115 -98%
SSA
37
Schonfeld Strategic Advisors
New York
– -$44K -106 Closed
CS
38
Credit Suisse
Switzerland
– -$40K -97 Closed
Simplex Trading
39
Simplex Trading
Illinois
– -$27.9K -69 Closed
Citigroup
40
Citigroup
New York
– -$11K -26 Closed
TRCT
41
Tower Research Capital (TRC)
New York
– -$5K -13 Closed
Osaic Holdings
42
Osaic Holdings
Arizona
– -$1.21K -3 Closed
1
2

TPST Hedge Fund Activity: Q1 2021 in Review

30 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q1 2021, worth a combined $8.5M — down 48% from $16.4M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of TPST and 5 opened new positions — a net loss of 7 holders — while 7 trimmed existing stakes and 10 added.

The largest buyer was Ikarian Capital, adding an estimated $2.51M. The largest seller was Commodore Capital, exiting entirely with an estimated $1.98M sold.

  • 30 institutional investors held Tempest Therapeutics (TPST) as of Q1 2021, down from 37 in Q4 2020.
  • Funds reported $8.5M of Tempest Therapeutics stock for Q1 2021, down 48% quarter-over-quarter.
  • 5 funds opened new Tempest Therapeutics positions in Q1 2021 and 12 closed out, a net change of -7 holders.
  • The largest Tempest Therapeutics buyer in Q1 2021 was Ikarian Capital, an estimated $2.51M added.
  • The largest Tempest Therapeutics seller in Q1 2021 was Commodore Capital, an estimated $1.98M sold.

Based on aggregated 13F filings for Q1 2021.